Immuron Limited (IMRN): Price and Financial Metrics
IMRN Price/Volume Stats
| Current price | $1.70 | 52-week high | $2.87 |
| Prev. close | $1.76 | 52-week low | $1.50 |
| Day low | $1.69 | Volume | 16,400 |
| Day high | $1.79 | Avg. volume | 22,392 |
| 50-day MA | $1.79 | Dividend yield | N/A |
| 200-day MA | $2.05 | Market Cap | 9.93M |
IMRN Stock Price Chart Interactive Chart >
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
IMRN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IMRN Price Returns
| 1-mo | -8.60% |
| 3-mo | N/A |
| 6-mo | -15.00% |
| 1-year | -26.09% |
| 3-year | -41.78% |
| 5-year | N/A |
| YTD | 0.00% |
| 2024 | -9.33% |
| 2023 | -9.86% |
| 2022 | -16.80% |
| 2021 | N/A |
| 2020 | N/A |